Back to search
FDAFDA · Food and drugs·Recall number D-0957-2017

0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.

Published July 19, 2017 · Recall initiated: July 6, 2017

Summary

FDA records drug Class II recall D-0957-2017, published July 19, 2017 and initiated July 6, 2017. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 131,904 bags; Lot: Lot: Y229153, Exp 09/30/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Customer complaints for leaking bags.

What to do

Voluntary: Firm initiated · Letter

Get an email if SODIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM CHLORIDE
Manufacturer
Baxter Healthcare Corporation
Distributor
Nationwide in USA
Lot
Lot: Y229153, Exp 09/30/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02. recalled?

Yes. FDA published recall D-0957-2017 on July 19, 2017. Reported hazard: Lack of Assurance of Sterility: Customer complaints for leaking bags.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM CHLORIDE.